FDA recall D-0051-2027

Pfizer · Class II · drug

Product

Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 1000-count bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-10

Reason for recall

Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.

Distribution

US Nationwide and Puerto Rico

Key facts

Status
Ongoing
Initiation date
2026-09-29
Report date
2026-10-28
Voluntary/Mandated
Voluntary: Firm initiated
Location
Manhattan, NY, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0051-2027